High Levels of Protection Against Acute and Chronic Toxoplasmosis in Institute of Cancer Research Mice with a Novel Low-Temperature Inactivated Toxoplasma gondii Candidate Vaccine Adjuvanted with HA201/HA203
Foodborne Pathogens and Disease · 01.08.2026 · 23 (8) · 547-554
DOI: 10.1089/fpd.2024.0159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foodborne Pathogens and Disease, online erschienen am 07.07.2025. Verfasst von Shao-Yuan Bai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Comparative Medicine, College of Veterinary Medicine, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infect…. Hauptthemen laut MEDLINE: Toxoplasma, Protozoan Vaccines, Adjuvants, Vaccine, Toxoplasmosis, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Toxoplasma gondii is a highly complex protozoan parasite that poses significant health risks to humans and livestock. Traditional inactivated vaccines have simple preparation and high safety characteristics, but the protection is insufficient. This study aimed to find a new way to prepare an inactivated vaccine and find a suitable adjuvant to evaluate the immunoprotection. Inactivated vaccine (IVAC) was prepared by a novel low-temperature inactivation method, and different adjuvants were selected to evaluate the immune response. To assess immune protection, cytokines and other quantifiable factors associated with protection were examined, and then acute and chronic immune-protected experiments were carried out. IVAC has good integrity and biosafety. Immunizing mice with the adjuvant vaccine resulted in increased immunoglobulin G antibody and interferon-gamma levels, indicating the induction of a mixed Th1/Th2 immune response. Most notably, vaccination significantly improved the survival rate of mice. The IVAC can achieve a 10% protection rate, and the protection rate with adjuvant HA201 and HA203 can reach 50% and 70%, respectively. We found a new method to prepare IVAC and identified two adjuvants that could improve survival rates by 40–60%. These results provide valuable insights for future research on the Toxoplasma vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Comparative Medicine, College of Veterinary Medicine, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, and Jiangsu Key Laboratory of Zoonosis, Ya…
- Chongqing Academy of Animal Sciences, Chongqing, PR China.
ORCID-Profile: Si-Yang Huang
Zitieren
APA
Bai, S. Y., Zhou, G. Q., Li, Y. Y., Pan, M., Fu, L., & Huang, S. Y. (2026). High Levels of Protection Against Acute and Chronic Toxoplasmosis in Institute of Cancer Research Mice with a Novel Low-Temperature Inactivated Toxoplasma gondii Candidate Vaccine Adjuvanted with HA201/HA203. Foodborne Pathogens and Disease, 23(8), 547-554. https://doi.org/10.1089/fpd.2024.0159
Vancouver
Bai SY, Zhou GQ, Li YY, Pan M, Fu L, Huang SY. High Levels of Protection Against Acute and Chronic Toxoplasmosis in Institute of Cancer Research Mice with a Novel Low-Temperature Inactivated Toxoplasma gondii Candidate Vaccine Adjuvanted with HA201/HA203. Foodborne Pathogens and Disease. 2026;23(8):547-554. doi:10.1089/fpd.2024.0159
BibTeX
@article{Bai2026,
author = {Bai, Shao-Yuan and Zhou, Guo-Qing and Li, Yu-Yuan and Pan, Ming and Fu, Lizhi and Huang, Si-Yang},
title = {High Levels of Protection Against Acute and Chronic Toxoplasmosis in Institute of Cancer Research Mice with a Novel Low-Temperature Inactivated Toxoplasma gondii Candidate Vaccine Adjuvanted with HA201/HA203},
journal = {Foodborne Pathogens and Disease},
year = {2026},
volume = {23},
number = {8},
pages = {547--554},
doi = {10.1089/fpd.2024.0159}
}
EUVIMED